More SEC Filings
View Older Stories View Newer Stories-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Harmon Cyrus
-
Form 497 AIM ETF Products Trust
-
Form 6-K Rubico Inc. For: Jun 23
-
Form 424B2 BANK OF NOVA SCOTIA
-
Form 424B2 CITIGROUP INC
-
Form D CRED RN-D Cayman Unit
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: BUTITTA CYNTHIA M
-
Form 4 Guardant Health, Inc. For: Jun 22 Filed by: Tariq Musa
-
Form 11-K JANUS HENDERSON GROUP For: Dec 31
-
Form 4 Guardant Health, Inc. For: Jun 22 Filed by: POTTER MYRTLE S
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Garland J. Scott
-
Form 8-K ENANTA PHARMACEUTICALS For: Jun 23
-
Form 425 Evernorth Holdings Inc. Filed by: Evernorth Holdings Inc.
-
Form 4 Guardant Health, Inc. For: May 21 Filed by: MIGNONE ROBERTO
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Hrustanovic Gorjan
-
Form FWP BofA Finance LLC Filed by: BofA Finance LLC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 CITIGROUP INC
-
Form FWP BANK OF AMERICA CORP Filed by: BANK OF AMERICA CORP /DE/
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: CLARK IAN T
-
Form 424B2 BofA Finance LLC
-
Form 424B3 CNL Strategic Capital,
-
Form D Kalea Ventures Funds
-
Form 424B2 HSBC USA INC /MD/
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Larson Yi
-
Form 6-K/A VivoPower PLC For: Jun 23
-
Form 11-K Liberty Energy Inc. For: Dec 31
-
Form D/A CAZ Private Equity Owner
-
Form 11-K Ingersoll Rand Inc. For: Dec 31
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: Ballal Rahul D.
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 425 Axalta Coating Systems Filed by: AKZO NOBEL NV
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Horning Sandra
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: CAPELLO JEFFREY D
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4 Indivior Pharmaceuticals For: Jun 22 Filed by: Ciaffoni Joseph
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: Foster-Cheek Kaye I
-
Form APP ORDR J.P. Morgan Investment
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 8-K CNL Strategic Capital, For: Jun 23
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Raman Prakash
-
Form 424B2 BofA Finance LLC
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form APP NTC J.P. Morgan Investment
-
Form DEF 14A 22nd Century Group, Inc. For: Jun 23
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: FOUSE JACQUALYN A
-
Form 424B2 CITIGROUP INC

